Skip to main content
Explore URMC
URMC / Research / Clinical Trials / Study Details

ULEU07047 / RSRB20123 / Michael Becker

Basic Study Information

This study is being performed to develop assays to determine the impact of the therapy patients receive for treatment of AML or MDS and to determine if these tests can identify those patients who are at a greater risk for having their disease relapse.

Location: University of Rochester Medical Center

Lead Researcher (Principal Investigator)

Lead Researcher:  Michael Becker, MD

Study Contact Information

Study Coordinator: Lauren Mitchell

Additional Study Details

Return to Search